Normal view MARC view ISBD view

Daclizumab (anti-CD25) in multiple sclerosis.

Pfender, Nikolai

Daclizumab (anti-CD25) in multiple sclerosis. [electronic resource] - Experimental neurology Dec 2014 - 44-51 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review

ISSN: 1090-2430

Standard No.: 10.1016/j.expneurol.2014.04.015 doi

Subjects--Topical Terms:
Antibodies, Monoclonal, Humanized--therapeutic use
Daclizumab
Humans
Immunoglobulin G--therapeutic use
Interleukin-2 Receptor alpha Subunit--immunology
Multiple Sclerosis--immunology

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)